Company: BLND
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001855747-25-000017
Chunk: 30

Company: Blend Labs, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 30
---
(In thousands)

Year Ended December 31, 2022Redeemable Noncontrolling InterestCommon StockAdditionalPaid-InCapitalAccumulatedOtherComprehensiveIncome (Loss)AccumulatedDeficitTotalStockholders’EquitySharesAmountBalances as of December 31, 2021    $35,949 230,324 $2 $1,218,213 $(808)$(442,765)$774,642 Issuance of common stock upon exercise of stock options, net of repurchases— 2,706 — 3,548 — — 3,548 Vesting of early exercised stock options— — — 4,060 — — 4,060 Vesting of restricted stock units— 7,901 — — — — — Stock-based compensation— — — 109,702 — — 109,702 Unrealized loss on investments in marketable securities— — — — (135)— (135)Foreign currency translation gain— — — — 235 — 235 Accretion of redeemable noncontrolling interest to redemption value48,438 — — (48,438)— — (48,438)Other— — — (270)— — (270)Net loss(43,638)— — — — (720,172)(720,172)Balances as of December 31, 2022    $40,749 240,931 $2 $1,286,815 $(708)$(1,162,937)$123,172 

See accompanying notes to consolidated financial statements

80

Blend Labs, Inc.

Consolidated Statements of Cash Flows

(In thousands)

Year Ended December 31,202420232022Operating activitiesNet loss$(43,419)$(179,879)$(763,810)Adjustments to reconcile net loss to net cash used in operating activities:Stock-based compensation28,07746,021109,702Depreciation and amortization2,2892,46410,766Impairment of intangible assets and goodwill——449,680Amortization of deferred contract costs1,0682,9794,638Amortization of debt discount and issuance costs6902,9683,058Amortization of operating lease right-of-use assets